Navigation Links
Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai

SHANGHAI, June 25 /PRNewswire-Asia/ -- In the afternoon of June 22, Shanghai Pudong Customs, Pudong International Airport Customs and Zhangjiang Group Co. held ceremony in the Zhangjiang Hi-Tech Park to initiate the Express Customs Clearance for 3 biopharmaceutical R&D outsourcing (CRO) companies. The selected CRO companies are Sundia MediTech, Huiyuan Biotechnology, and Frontage Laboratories from Zhangjiang Hi-Tech Park. This event marked the formal start of the trial operation of a new customs clearance model for CRO companies in Zhangjiang.

Sundia's Chairman and CEO Dr. Xiaochuan Wang and Executive VP Dr. Xiongwei Shi attended the ceremony with representatives from many biopharmaceutical companies. Ms. Liu Zhengyi, Deputy Director of the Pudong District Government was at the ceremony to extend her congratulations. Mr. Ma Yan, Director of Pudong Customs, Mr. Shi Wenyan, Director of Pudong International Airport Customs, and Mr. Liu Xiaolong, Executive VP of Zhangjiang Group Co. signed a Letter of Intention for Customs' Cooperation to Support Development of Zhangjiang Pharma Valley.

Earlier this year, China Central Government adopted a policy to "encourage service outsourcing industry". High level officials, including Premier Wen Jiabao called on strong support to this industry. As a key part of service outsourcing, CRO companies in Zhangjiang get more and more attention. With growing innovative capability and national influence, the reputation and strength of Zhangjiang Pharma Valley has become more prominent as it turns into the most developed CRO base in China.

With the rapid growth of the CRO industry, customs clearance efficiency becomes a significant bottleneck for CRO companies due to high import/export volume, numerous categories, new products, strict storage requirements, etc. Fast customs clearance has become the most pressing need of CRO companies. Therefore, Shanghai Pudong Customs and Pudong International Airport Customs jointly proposed selecting some CRO companies in the Zhangjiang High-Tech Park for trial operation of express clearance, which implements various measures including "declaration in advance and clearance upon goods arrival", "archiving system of classification and price review", "assured clearance" and "24-hour appointed clearance", to establish a new customs clearance model for CRO companies and achieve a balance between strict supervision and efficient operation.

The first 3 CRO companies were recommended by Zhangjiang Park to governing customs after considering various factors such as company reputation, track record, size, and status. Then they were selected by customs after strict review and screening regarding the companies' credibility, internal management system, laboratory qualification and customs clearance record.

At present, customs is gradually putting more effort into the trial operation. The next step will be expanding the operation within Zhangjiang Park on the basis of previous experience so that more companies can benefit from the new measures, and better service can be provided to help the growth of CRO industry.

"This is really a big step by Chinese customs to support the growth of Sundia and other CRO companies. We are encouraged by this and many other measures the Chinese Government put together to help the development of CRO industry," commented by Dr. Xiaochuan Wang, Sundia's Chairman and CEO.

About Sundia MediTech Company:

Sundia is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. Sundia provides services to biotech and pharmaceutical companies worldwide, ranging from early hit screening, biological service, lead optimization, DMPK, candidate preclinical development, formulation development, API manufacture, and regulatory submission. For more information, please visit .

SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sundias Animal Facility Passed Client and Government Inspection
2. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
3. Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
4. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
5. CEL-SCI Files Patent Application to Support Companys Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses
6. Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
7. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
8. Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting
9. AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer
10. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
Post Your Comments:
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 ... HART ), a biotechnology company developing bioengineered organ implants ... McGorry will present at the LD Micro "Main ... 2:30 p.m. PT. The presentation will be webcast live ... Management will also be available at the conference for ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
(Date:11/24/2015)... ... , ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, ... annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to ... Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the department ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper ... unless it is bound to proteins, copper is also toxic to cells. With ... Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper in the ...
Breaking Biology Technology:
(Date:11/19/2015)... YORK , Nov. 19, 2015  Although some ... market is dominated by a few companies, according to ... companies own 51% of the market share of the ... The World Market for Molecular Diagnostic s ... "The market is still controlled by one company ...
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
Breaking Biology News(10 mins):